http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1885385-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a84959e9a27c67dd120c9c839fcddd7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7084 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 2006-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9138a25e0f33ba034c238e0ddc59b4db |
| publicationDate | 2008-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1885385-A2 |
| titleOfInvention | Phosphatidylinositol combination composition and 3'-phosphorylated lysophosphatidylinositols in the treatment of cancer and autoimmune diseases |
| abstract | The invention relates to a combination or a combination compound comprising a 31-phosphorylated form of phosphatidylinositol and a secretory (s) phospholipase A2. Also provided are pharmaceutical compositions comprising 3'-phosphorylated lyso-phosphatidylinositols. Furthermore, the invention relates to a pharmaceutical composition comprising the combination or combination compound of the invention. Moreover, the present invention provides for the use of a combination or a combination compound of the invention, for a preparation of a pharmaceutical composition for the treatment of a proliferative disorder and/or tumorous disease. Moreover, the present invention provides for a method for the generation of a cellular lysate of normal or tumorous/tumor cells comprising the steps of: (a) contacting non-tumorous cells or tumorous/tumor cells with the combination or combination compound of the invention; and (b) obtaining the resulting cellular lysate. |
| priorityDate | 2005-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 547.